Literature DB >> 20189224

Analysis of tissue factor positive microparticles.

Nigel S Key1.   

Abstract

There has recently been intense interest in the clinical measurement of tissue factor (TF)-positive microparticles (MPs) in clinical disease states. This interest has been driven by the demonstration of an putative role for circulating TF-positive MPs in animal models of thrombus propagation. Both immunological and functional assays for MP-TF have been described. While each approach has its own advantages and drawbacks, neither has yet been truly established as the 'gold standard'. Heterogeneity of TF-bearing MPs, such as the variable co-expression of surface phosphatidylserine, may determine not only their procoagulant potential, but also additional properties including rate of clearance from the circulation. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189224      PMCID: PMC2847734          DOI: 10.1016/j.thromres.2010.01.035

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  45 in total

1.  In situ localization of tissue factor in human thrombi.

Authors:  Jacques Himber; Dorothée Kling; John T Fallon; Yale Nemerson; Markus A Riederer
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

2.  Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis.

Authors:  Joaquin J Jimenez; Wenche Jy; Lucia M Mauro; Carl Soderland; Lawrence L Horstman; Yeon S Ahn
Journal:  Thromb Res       Date:  2003-02-15       Impact factor: 3.944

3.  Measuring circulating cell-derived microparticles.

Authors:  W Jy; L L Horstman; J J Jimenez; Y S Ahn; E Biró; R Nieuwland; A Sturk; F Dignat-George; F Sabatier; L Camoin-Jau; J Sampol; B Hugel; F Zobairi; J M Freyssinet; S Nomura; A S Shet; N S Key; R P Hebbel
Journal:  J Thromb Haemost       Date:  2004-10       Impact factor: 5.824

4.  Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.

Authors:  U Rauch; D Bonderman; B Bohrmann; J J Badimon; J Himber; M A Riederer; Y Nemerson
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

5.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.

Authors:  Shahrokh Falati; Peter Gross; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

6.  Inhibition of tissue factor limits the growth of venous thrombus in the rabbit.

Authors:  J Himber; C Wohlgensinger; S Roux; L A Damico; J T Fallon; D Kirchhofer; Y Nemerson; M A Riederer
Journal:  J Thromb Haemost       Date:  2003-05       Impact factor: 5.824

7.  Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay.

Authors:  Veronique Ollivier; Jianguo Wang; David Manly; Kellie R Machlus; Alisa S Wolberg; Martine Jandrot-Perrus; Nigel Mackman
Journal:  Thromb Res       Date:  2009-04-05       Impact factor: 3.944

8.  Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.

Authors:  H F Dvorak; L Van DeWater; A M Bitzer; A M Dvorak; D Anderson; V S Harvey; R Bach; G L Davis; W DeWolf; A C Carvalho
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

9.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

Authors:  Arun S Shet; Omer Aras; Kalpna Gupta; Mathew J Hass; Douglas J Rausch; Nabil Saba; Louann Koopmeiners; Nigel S Key; Robert P Hebbel
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

10.  Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.

Authors:  Omer Aras; Arun Shet; Ronald R Bach; Jessica L Hysjulien; Arne Slungaard; Robert P Hebbel; Gines Escolar; Bernd Jilma; Nigel S Key
Journal:  Blood       Date:  2004-02-26       Impact factor: 22.113

View more
  20 in total

Review 1.  Infusible platelet membrane as a platelet substitute for transfusion: an overview.

Authors:  Saleh Nasiri
Journal:  Blood Transfus       Date:  2013-05-14       Impact factor: 3.443

Review 2.  Algorithms for managing coagulation disorders in liver disease.

Authors:  R Todd Stravitz
Journal:  Hepatol Int       Date:  2018-07-31       Impact factor: 6.047

3.  Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects.

Authors:  Anastasios G Kriebardis; Marianna H Antonelou; Hara T Georgatzakou; Vassilis L Tzounakas; Konstantinos E Stamoulis; Issidora S Papassideri
Journal:  Blood Transfus       Date:  2016-02-22       Impact factor: 3.443

4.  Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosis.

Authors:  Christine M Alvarado; Jose A Diaz; Angela E Hawley; Shirley K Wrobleski; Robert E Sigler; Daniel D Myers
Journal:  Thromb Res       Date:  2011-02-05       Impact factor: 3.944

5.  A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.

Authors:  Aimee C Hodowanec; Rebecca D Lee; Kirsten E Brady; Weihua Gao; Stacey Kincaid; Jill Plants; Mieoak Bahk; Nigel Mackman; Alan L Landay; Gregory D Huhn
Journal:  BMC Infect Dis       Date:  2015-04-17       Impact factor: 3.090

6.  Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure.

Authors:  R Todd Stravitz; Regina Bowling; Robert L Bradford; Nigel S Key; Sam Glover; Leroy R Thacker; Don A Gabriel
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

7.  Phosphatidylethanolamine is externalized at the surface of microparticles.

Authors:  Michael C Larson; Jeffrey E Woodliff; Cheryl A Hillery; Tyce J Kearl; Ming Zhao
Journal:  Biochim Biophys Acta       Date:  2012-08-30

8.  Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy.

Authors:  Nena Matijevic; Yao-Wei W Wang; Charles E Wade; John B Holcomb; Bryan A Cotton; Martin A Schreiber; Peter Muskat; Erin E Fox; Deborah J Del Junco; Jessica C Cardenas; Mohammad H Rahbar; Mitchell Jay Cohen
Journal:  Thromb Res       Date:  2014-07-22       Impact factor: 3.944

9.  Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status.

Authors:  Xuguang Zhang; Susan C McGeoch; Alexandra M Johnstone; Grietje Holtrop; Alan A Sneddon; Sandra M MacRury; Ian L Megson; Donald W M Pearson; Prakash Abraham; Baukje De Roos; Gerald E Lobley; Niamh O'Kennedy
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

Review 10.  Circulating microparticles: square the circle.

Authors:  Natasha S Barteneva; Elizaveta Fasler-Kan; Michael Bernimoulin; Joel N H Stern; Eugeny D Ponomarev; Larry Duckett; Ivan A Vorobjev
Journal:  BMC Cell Biol       Date:  2013-04-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.